Use of rifabutin in treatment of systemic Mycobacterium paratuberculosis infection in mice.

BALB/c mice were infected intraperitoneally with Mycobacterium paratuberculosis and, after allowing the infection to progress for 30 days, were treated with rifabutin at 0, 12.5, 25, and 50 mg/kg of body weight. Rifabutin was administered in drinking water under conditions of water deprivation, wher...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Chiodini, R J, Kreeger, J M, Thayer, W R
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1993
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC188034/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8215277/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.37.8.1645
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!